Charming Medical Receives Nasdaq Delisting Notice Effective November 2026
Charming Medical (MCTA) announced on Thursday that it has received a formal delisting notice from the Nasdaq stock exchange. According to the notification, the company's securities are scheduled to cease trading on the exchange effective November 9, 2026. The company has indicated that it maintains the right to appeal the Nasdaq determination. This development introduces significant regulatory uncertainty regarding the company's ability to maintain its current listing status on a major public exchange.